Search Results 111-120 of 16763 for GLP-1 agonists
Benefits of Glucagon-like Peptide-1 Receptor Agonists After Kidney Transplantation. Endocr Pract. 2025 Jun; 31 (6):798-804 Epub 2025 Mar 05. View PubMed ...
... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after ... Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to ...
Treatment with GLP-1 agonists and amlyin which cause vagal blockade and may affect central processing of pain. Positive tissue transglutaminase antibodies ...
Ongoing treatment with GLP-1 or amylin analogues or agonists. Any elective major surgery planned or anticipated at any time during the study. History of ...
The association between glucagon-like peptide 1 receptor agonists therapy and outcomes after heart transplant. J Heart Lung Transplant. 2026 Jan 9 Epub 2026 ...
Are on chronic opioids or other medications known to affect gastric emptying (e.g., GLP-1 agonists, high dose tricyclic agents);; Have been recently ...
Patients on long-acting glucagon-like peptide (GLP-1). Active implantable devices ... Unable to stop medications that may alter GI motility (GLP-1 agonists ...
... 1 year prior to Visit 1;; Subjects 2-6 years of age: Diagnosed at least 3 ... GLP-1 agonists), metformin, canagliflozin (Invokana or other SGLT2 inhibitors) at ...
Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia. ... (GLP-1RA) and Gastric Point ...
Black ML, Coyle CG, Bernet VJ, McLeod CJ, Chindris AM. Delayed-Onset Amiodarone Induced Thyrotoxicosis After Glucagon-Like Peptide-1 Agonist-Related Weight Loss ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.